Cargando…

The p48 MW flow modulation device for treatment of unruptured, saccular intracranial aneurysms: a single center experience from 77 consecutive aneurysms

BACKGROUND: The p48 MW Flow Modulation Device (phenox, Bochum Germany) is a low profile flow diverter stent (FDS), designed for implantation into intracranial arteries with a diameter of less than 3.5 mm. OBJECTIVE: To evaluate the safety and efficacy of the p48 MW FDS in the treatment of unruptured...

Descripción completa

Detalles Bibliográficos
Autores principales: AlMatter, Muhammad, Henkes, Elina, Sirakov, Alexander, Aguilar Pérez, Marta, Hellstern, Victoria, Serna Candel, Carmen, Ganslandt, Oliver, Henkes, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415468/
https://www.ncbi.nlm.nih.gov/pubmed/32776195
http://dx.doi.org/10.1186/s42155-020-00131-4
_version_ 1783569182339629056
author AlMatter, Muhammad
Henkes, Elina
Sirakov, Alexander
Aguilar Pérez, Marta
Hellstern, Victoria
Serna Candel, Carmen
Ganslandt, Oliver
Henkes, Hans
author_facet AlMatter, Muhammad
Henkes, Elina
Sirakov, Alexander
Aguilar Pérez, Marta
Hellstern, Victoria
Serna Candel, Carmen
Ganslandt, Oliver
Henkes, Hans
author_sort AlMatter, Muhammad
collection PubMed
description BACKGROUND: The p48 MW Flow Modulation Device (phenox, Bochum Germany) is a low profile flow diverter stent (FDS), designed for implantation into intracranial arteries with a diameter of less than 3.5 mm. OBJECTIVE: To evaluate the safety and efficacy of the p48 MW FDS in the treatment of unruptured aneurysms located at intracranial arteries with less than 3.5 mm diameter based on a retrospective analysis from a single tertiary neurovascular center. METHODS: A prospectively maintained database was retrospectively reviewed to identify all cases of intracranial saccular aneurysms treated electively with the p48 MW device. Records were made of basic demographics, aneurysmal characteristics, interventional procedures, adverse events, clinical outcomes and occlusion rates on angiographic follow-ups. RESULTS: A total of 77 aneurysms and 74 patients were included. The mean size of the treated aneurysms was 3.5 ± 2.4 mm and the mean aspect ratio was 1.3 ± 0.4. A total of 80 endovascular procedures were performed with a total of 12 (15%) adverse events leading to two (2.5%) permanent morbidities/mortalities. Technical issues were encountered in 3 (3.9%) cases. Adequate occlusion of the treated aneurysm was recorded in 55.6% and 63.9% on the first and latest available DSA follow-ups, respectively. There were no cases of side-branch occlusion. CONCLUSIONS: The p48 MW is an easy-to-use implant with very good safety margins. Side branch occlusion and significant in-stent stenosis are infrequently encountered. The time from implantation to sufficient aneurysm occlusion takes longer than with FDS with lower porosity.
format Online
Article
Text
id pubmed-7415468
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-74154682020-08-13 The p48 MW flow modulation device for treatment of unruptured, saccular intracranial aneurysms: a single center experience from 77 consecutive aneurysms AlMatter, Muhammad Henkes, Elina Sirakov, Alexander Aguilar Pérez, Marta Hellstern, Victoria Serna Candel, Carmen Ganslandt, Oliver Henkes, Hans CVIR Endovasc Original Article BACKGROUND: The p48 MW Flow Modulation Device (phenox, Bochum Germany) is a low profile flow diverter stent (FDS), designed for implantation into intracranial arteries with a diameter of less than 3.5 mm. OBJECTIVE: To evaluate the safety and efficacy of the p48 MW FDS in the treatment of unruptured aneurysms located at intracranial arteries with less than 3.5 mm diameter based on a retrospective analysis from a single tertiary neurovascular center. METHODS: A prospectively maintained database was retrospectively reviewed to identify all cases of intracranial saccular aneurysms treated electively with the p48 MW device. Records were made of basic demographics, aneurysmal characteristics, interventional procedures, adverse events, clinical outcomes and occlusion rates on angiographic follow-ups. RESULTS: A total of 77 aneurysms and 74 patients were included. The mean size of the treated aneurysms was 3.5 ± 2.4 mm and the mean aspect ratio was 1.3 ± 0.4. A total of 80 endovascular procedures were performed with a total of 12 (15%) adverse events leading to two (2.5%) permanent morbidities/mortalities. Technical issues were encountered in 3 (3.9%) cases. Adequate occlusion of the treated aneurysm was recorded in 55.6% and 63.9% on the first and latest available DSA follow-ups, respectively. There were no cases of side-branch occlusion. CONCLUSIONS: The p48 MW is an easy-to-use implant with very good safety margins. Side branch occlusion and significant in-stent stenosis are infrequently encountered. The time from implantation to sufficient aneurysm occlusion takes longer than with FDS with lower porosity. Springer International Publishing 2020-08-09 /pmc/articles/PMC7415468/ /pubmed/32776195 http://dx.doi.org/10.1186/s42155-020-00131-4 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Article
AlMatter, Muhammad
Henkes, Elina
Sirakov, Alexander
Aguilar Pérez, Marta
Hellstern, Victoria
Serna Candel, Carmen
Ganslandt, Oliver
Henkes, Hans
The p48 MW flow modulation device for treatment of unruptured, saccular intracranial aneurysms: a single center experience from 77 consecutive aneurysms
title The p48 MW flow modulation device for treatment of unruptured, saccular intracranial aneurysms: a single center experience from 77 consecutive aneurysms
title_full The p48 MW flow modulation device for treatment of unruptured, saccular intracranial aneurysms: a single center experience from 77 consecutive aneurysms
title_fullStr The p48 MW flow modulation device for treatment of unruptured, saccular intracranial aneurysms: a single center experience from 77 consecutive aneurysms
title_full_unstemmed The p48 MW flow modulation device for treatment of unruptured, saccular intracranial aneurysms: a single center experience from 77 consecutive aneurysms
title_short The p48 MW flow modulation device for treatment of unruptured, saccular intracranial aneurysms: a single center experience from 77 consecutive aneurysms
title_sort p48 mw flow modulation device for treatment of unruptured, saccular intracranial aneurysms: a single center experience from 77 consecutive aneurysms
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415468/
https://www.ncbi.nlm.nih.gov/pubmed/32776195
http://dx.doi.org/10.1186/s42155-020-00131-4
work_keys_str_mv AT almattermuhammad thep48mwflowmodulationdevicefortreatmentofunrupturedsaccularintracranialaneurysmsasinglecenterexperiencefrom77consecutiveaneurysms
AT henkeselina thep48mwflowmodulationdevicefortreatmentofunrupturedsaccularintracranialaneurysmsasinglecenterexperiencefrom77consecutiveaneurysms
AT sirakovalexander thep48mwflowmodulationdevicefortreatmentofunrupturedsaccularintracranialaneurysmsasinglecenterexperiencefrom77consecutiveaneurysms
AT aguilarperezmarta thep48mwflowmodulationdevicefortreatmentofunrupturedsaccularintracranialaneurysmsasinglecenterexperiencefrom77consecutiveaneurysms
AT hellsternvictoria thep48mwflowmodulationdevicefortreatmentofunrupturedsaccularintracranialaneurysmsasinglecenterexperiencefrom77consecutiveaneurysms
AT sernacandelcarmen thep48mwflowmodulationdevicefortreatmentofunrupturedsaccularintracranialaneurysmsasinglecenterexperiencefrom77consecutiveaneurysms
AT ganslandtoliver thep48mwflowmodulationdevicefortreatmentofunrupturedsaccularintracranialaneurysmsasinglecenterexperiencefrom77consecutiveaneurysms
AT henkeshans thep48mwflowmodulationdevicefortreatmentofunrupturedsaccularintracranialaneurysmsasinglecenterexperiencefrom77consecutiveaneurysms
AT almattermuhammad p48mwflowmodulationdevicefortreatmentofunrupturedsaccularintracranialaneurysmsasinglecenterexperiencefrom77consecutiveaneurysms
AT henkeselina p48mwflowmodulationdevicefortreatmentofunrupturedsaccularintracranialaneurysmsasinglecenterexperiencefrom77consecutiveaneurysms
AT sirakovalexander p48mwflowmodulationdevicefortreatmentofunrupturedsaccularintracranialaneurysmsasinglecenterexperiencefrom77consecutiveaneurysms
AT aguilarperezmarta p48mwflowmodulationdevicefortreatmentofunrupturedsaccularintracranialaneurysmsasinglecenterexperiencefrom77consecutiveaneurysms
AT hellsternvictoria p48mwflowmodulationdevicefortreatmentofunrupturedsaccularintracranialaneurysmsasinglecenterexperiencefrom77consecutiveaneurysms
AT sernacandelcarmen p48mwflowmodulationdevicefortreatmentofunrupturedsaccularintracranialaneurysmsasinglecenterexperiencefrom77consecutiveaneurysms
AT ganslandtoliver p48mwflowmodulationdevicefortreatmentofunrupturedsaccularintracranialaneurysmsasinglecenterexperiencefrom77consecutiveaneurysms
AT henkeshans p48mwflowmodulationdevicefortreatmentofunrupturedsaccularintracranialaneurysmsasinglecenterexperiencefrom77consecutiveaneurysms